Kathleen P. Gallagher Avidity Biosciences, Inc. (RNA) insider trading activity

Kathleen P. Gallagher is Chief Program Officer of Avidity Biosciences, Inc.. Currently has a direct ownership of 50,554 shares of RNA, which is worth approximately $1.62 Million. The most recent transaction as insider was on Mar 03, 2025, when has been sold 5,875 shares (Common Stock) at a price of $29.41 per share, resulting in proceeds of $172,783. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 50.6K

n/a 3M change

n/a 12M change

Total Value Held $1.62 Million

Kathleen P. Gallagher Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Date	Transaction	Value	Shares Traded	Shares Held	Form
Mar 03 2025	SELL Open market or private sale	$172,783 $29.41 p/Share	5,875 Reduced 10.41%	50,554 Common Stock
Mar 03 2025	BUY Exercise of conversion of derivative security	$86,362 $14.7 p/Share	5,875 Added 9.43%	56,429 Common Stock
Feb 03 2025	SELL Open market or private sale	$188,939 $32.16 p/Share	5,875 Reduced 10.41%	50,554 Common Stock
Feb 03 2025	BUY Exercise of conversion of derivative security	$97,818 $16.65 p/Share	5,875 Added 9.43%	56,429 Common Stock
Jan 22 2025	SELL Open market or private sale	$169,770 $30.16 p/Share	5,629 Reduced 10.02%	50,554 Common Stock
Jan 21 2025	SELL Open market or private sale	$108,127 $28.59 p/Share	3,782 Reduced 6.31%	56,183 Common Stock
Jan 06 2025	BUY Grant, award, or other acquisition	-	25,000 Added 29.42%	59,965 Common Stock

KPG

Kathleen P. Gallagher

Chief Program Officer

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RNA shares.

Notify only if

Value

Any

Insider Trading

Get notified when an Avidity Biosciences, Inc. insider buys or sells RNA shares.

Notify only if

Operation

Any

Value

Any

Type

P - Open market or private purchase×

S - Open market or private sale×

V - Transaction voluntarily reported earlier than required×

A - Grant, award, or other acquisition×

D - Sale (or disposition) back to the issuer×

F - Payment of exercise price or tax liability×

I - Discretionary transaction×

M - Exercise of conversion of derivative security×

C - Conversion of derivative security×

E - Expiration of short derivative position×

H - Expiration (or cancellation) of long derivative position with value received×

O - Exercise of out-of-the-money derivative securities×

X - Exercise of in-the-money or at-the-money derivatives securities×

G - Bona fide gift×

L - Small Acquisition×

W - Acquisition or disposition by will or laws×

Z - Deposit into or withdrawal from voting trust×

J - Other acquisition or disposition×

K - Transaction in equity swap or similar instrument×

U - Disposition due to a tender of shares in a change of control transaction×

20 item(s) selected

News

Receive news related to Avidity Biosciences, Inc.

Track Activities on RNA

Account